1Cancer Research Horizons, CRUK, The Francis Crick Institute, London, UK
2Cancer Research UK, London, UK
3Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
4Illumina Cambridge, Great Abington, Cambridge, UK
5All Wales Medical Genomics Service, University Hospital of Wales, Cardiff, UK
6The Centre for Molecular Pathology, The Royal Marsden, Sutton, UK
7West Midlands Regional Genetics Laboratory, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
8Genpax AG, Cambridge, UK
9Independent patient representative, Sandwell, West Midlands UK
10Pfizer, Global Product Development Oncology, San Diego, CA USA
11AstraZeneca, Late Development Oncology, Academy House, Cambridge, UK
12The Royal Marsden Hospital NHS Foundation Trust, London, UK
13Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK
14School of Cancer Sciences, University of Southampton, Southampton, UK
15The Francis Crick Institute, Midland Road, London, UK
16Wellcome Trust, London, UK
17Eli Lilly, London, UK
18British Heart Foundation, Bromley, UK
19Silence Therapeutics, London, UK
20Parexel, London, UK
21Ahead Care and Support, London, UK
Corresponding author.
#Contributed equally.
Subject terms: Biomarkers, Cancer genomics